HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

AmerisourceBergen Merger Complete, FTC Says Efficiencies Justify Approval

This article was originally published in The Tan Sheet

Executive Summary

Federal Trade Commission approval of the merger of AmeriSource and Bergen Brunswig reflects the agency's conclusion that the combined firm will be able to expand its services more rapidly than either company on its own.

You may also be interested in...



AmerisourceBergen Looking To Expand Packaging, National Chain Sales

AmerisourceBergen will be looking for acquisitions to enhance its non-distribution services for manufacturers and customers, the company told analysts Sept. 10 in New York.

AmeriSource Expects Post-Merger Market Share Of 33% To Pass FTC Review

AmeriSource and Bergen Brunswig predict the Federal Trade Commission will accept their combined 33% market share in the drug wholesaling sector without initiating an antitrust challenge.

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS131781

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel